FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:1507-1508 April 3, 2008 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

In this issue of the Journal, we publish the results of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial,¹ which addresses the question of whether additional lowering of low-density lipoprotein (LDL) cholesterol with ezetimibe beyond the level achieved with simvastatin beneficially affects the progression of atherosclerosis. As a surrogate clinical marker for such progression, the study used imaging of the intima–media thickness of the carotid and femoral arteries. In contrast to statins, which lower LDL cholesterol by increasing its clearance, ezetimibe selectively inhibits the absorption of cholesterol by binding to Niemann–Pick C1-like 1 (NPC1L1) protein, which is . . . [Full Text of this Article]

Source Information

This article (10.1056/NEJMe0801842) was published at www.nejm.org on March 30, 2008.

This article has been cited by other articles:

• Stebbing, J., Asghar, A. K., Holmes, P., Bower, M., Isenman, H. L., Nelson, M. (2008). Use of ezetimibe during HIV infection. J Antimicrob Chemother 0: dkn440v1-2 [Full Text]  
• Peto, R., Emberson, J., Landray, M., Baigent, C., Collins, R., Clare, R., Califf, R. (2008). Analyses of Cancer Data from Three Ezetimibe Trials. NEJM 359: 1357-1366 [Abstract] [Full Text]  
• Steinberg, D., Eichhorn, E. J., Connor, W. E., Diamond, G. A., Kaul, S., Blake, J. A., Davis, H. R. Jr., Murgolo, N. J., Graziano, M. P., Kaye, T., Akdim, F., de Groot, E., Kastelein, J. J.P., Brown, B. G. (2008). Simvastatin with or without ezetimibe in familial hypercholesterolemia.. NEJM 359: 529-530 [Full Text]  
• DAVIDSON, M. H. (2008). Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications. Cleveland Clinic Journal of Medicine 75: 479-496 [Full Text]  
• Repas, T. B. (2008). Think Beyond the Numbers, Don't Forget the Patient. JAOA: Journal of the American Osteopathic Association 108: ii-S4 [Full Text]